Top

Boston Scientific launches MRI-safe Resonate devices with HeartLogic diagnostic in U.S.

September 25, 2017

Boston Scientific (NYSE:BSX) launched today its Resonate implantable cardioverter defibrillator and cardiac resynchronization therapy defibrillator systems with the HeartLogic heart failure diagnostic tool.

The devices are approved by the FDA for conditional use in an MRI environment, the company reported.

Boston Scientific’s HeartLogic diagnostic warns doctors of worsening heart failure, collecting data from sensors monitoring heart sounds, thoracic impedance, heart rate and activity and respiration rate and volume.

Read More on Mass Device